Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Opinion Fellow Talk

The Evolving Role of Industry and the Interventional Cardiology Fellow

Poornima Mohan, MBChB

March 31, 2023

News Daily News

Top Structural Heart News of 2022

L.A. McKeown

January 06, 2023

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Daily News

Good TAVI Outcomes in Young Patients, but Population Is Unique

Michael O'Riordan

October 22, 2021

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Daily News

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

Shelley Wood

April 13, 2020

News CV Team Pro

The Providence St. Vincent Medical Center Cath Lab Team

L.A. McKeown

September 12, 2019

News Daily News

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

L.A. McKeown

April 19, 2019

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Daily News

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

L.A. McKeown

December 13, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

Advertisement

April 2025 Dispatch for the CV Team

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

The Evolving Role of Industry and the Interventional Cardiology Fellow

Top Structural Heart News of 2022

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Good TAVI Outcomes in Young Patients, but Population Is Unique

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns

The Providence St. Vincent Medical Center Cath Lab Team

Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Under Surveillance: Ballooning Numbers, Better Survival, Lower-Risk Patients in Latest TVT Registry Data

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content